Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2003
05/01/2003WO2002074292A3 Hormone replacement therapy
05/01/2003WO2002058685A3 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
05/01/2003WO2002048148A3 Pyrazolopyridine derivatives
05/01/2003WO2002046158A9 Piperidine/piperazine-type inhibitors of p38 kinase
05/01/2003WO2002038553A3 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists
05/01/2003WO2001098346A3 Methods and compositions for the treatment of peripheral artery disease
05/01/2003WO2001079291A3 Secreted proteins
05/01/2003WO2001024681A3 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same
05/01/2003US20030083739 For treating vascular in-stent restenosis; drug delivery
05/01/2003US20030083642 Devices and methods for the restoration of a spinal disc
05/01/2003US20030083509 Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
05/01/2003US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives
05/01/2003US20030083486 Physiologically active protein originating in mammals
05/01/2003US20030083466 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
05/01/2003US20030083374 NAALADase inhibitors useful as pharmaceutical compounds and compositions
05/01/2003US20030083363 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
05/01/2003US20030083353 Beta-secretase inhibitors
05/01/2003US20030083351 Antihypoxic agents
05/01/2003US20030083347 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
05/01/2003US20030083335 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP)
05/01/2003US20030083333 1,4-Disubstituted benzo-fused compounds
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
05/01/2003US20030083315 Benzimidazole derivatives for treating an inflammatory disease, an allergy disease, a respiratory disease, a cardiovascular disorder or a bone disorder
05/01/2003US20030083295 An oligonucleotides are hybridizable with nucleic acids to inhibit the gene expression of enzyme
05/01/2003US20030083286 Comprises penetration enhancer (fatty acid); drug delivery; increases bioavailability of oligonucleotides
05/01/2003US20030083280 Oligonucleotides which hybridize with nucleic acids which encode said protein; gene therapy; genetic engineering; for treatment of angina and myocardial infarction
05/01/2003US20030083272 Sense mrna therapy
05/01/2003US20030083258 Modulation of leukocyte-endothelial interactions following ischemia
05/01/2003US20030083254 Heparanase-like proteins and nucleotides that encode them
05/01/2003US20030083242 Methods and compositions for treating or preventing peripheral neuropathies
05/01/2003US20030082743 Polypeptide sequences of human EDG-1c
05/01/2003US20030082740 Antitumor agent for use in the treatment of cancer
05/01/2003US20030082725 DNA encoding a novel human inhibitor-of-apoptosis protein
05/01/2003US20030082636 Antibody for use as tool in the treatment of blood disorders
05/01/2003US20030082609 Nuceotide sequences coding polypeptide for use in humans therapeutics and diagnostics
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082513 Detecting cell to cell activity in sample; obtain cells, polarize, incubate with fluorescent dye, determine membrane potential of cells, monitor adjustment in membrane potenial between cells
05/01/2003US20030082243 Generation of therapeutic microfoam
05/01/2003US20030082230 Chronotherapeutic dosage forms and methods of treatment using chronotherapy
05/01/2003US20030082180 Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicament
05/01/2003US20030082169 System and method for the pretreatment of the endplates of an intervertebral disc
05/01/2003US20030082160 Differentiation of whole bone marrow
05/01/2003US20030082153 Stem cells that transform to beating cardiomyocytes
05/01/2003US20030082143 Filamentous phage particles having a ligand on surface for delivering a therapeutic gene to a cell; gene therapy
05/01/2003US20030082105 Selectively targeted fluorescent, radiolabeled, or fluorescent and radiolabeled compositions
05/01/2003CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003CA2466806A1 Method of resolving amlodipine racemate
05/01/2003CA2465261A1 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
05/01/2003CA2464943A1 Acarbose purification process
05/01/2003CA2464695A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003CA2464593A1 6-hydroxy isoflavones, derivatives and medicaments involving same
05/01/2003CA2464561A1 Methods of treatment using a gastric retained losartan dosage
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
05/01/2003CA2464331A1 Allium sativum bulb absolutes and therapeutic or cosmetic uses
05/01/2003CA2464271A1 Integrin targeting compounds
05/01/2003CA2464261A1 Apomorphine-containing dosage form for ameliorating male erectile dysfunction
05/01/2003CA2464111A1 Phosphonic acid compounds as inhibitors of serine proteases
05/01/2003CA2464088A1 Stem cells that transform to beating cardiomyocytes
05/01/2003CA2464085A1 A combination product comprising melagatran and dexamethasone
05/01/2003CA2463902A1 Functionalized stilbene derivatives as improved vascular targeting agents
05/01/2003CA2463803A1 Biphasic mixtures of glp-1 and insulin
05/01/2003CA2463758A1 Salts formed of an at1-receptor antagonist and a cardiovascular agent
05/01/2003CA2463311A1 Androgen receptor modulators and methods of use thereof
05/01/2003CA2463226A1 Acetic acid derivatives
05/01/2003CA2463101A1 Azole derivatives and pharmaceutical compositions containing them
05/01/2003CA2461543A1 Sperm factor sequences
05/01/2003CA2461159A1 Imidazopyridine compounds as 5-ht4 receptor modulators
05/01/2003CA2458958A1 Method and apparatus for dispensing inhalator medicament
05/01/2003CA2458828A1 Optimized dosing for drug coated stents
04/2003
04/30/2003CN1414965A Sulfonamides and derivatives thereof that modulate the activeity of endothelin
04/30/2003CN1414961A Substituted oximes and hydrazones as neurokinin antagonists
04/30/2003CN1414958A Nonpeptide substituted benzothiazepines as vasopressin antagonists
04/30/2003CN1414954A Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, method of production and pharmaceutical uses thereof
04/30/2003CN1414952A Heterocyclic compounds having sulfonic acid
04/30/2003CN1414950A Substituted pyrrole Mannich bases to treating paint and allergic reactions
04/30/2003CN1414871A Placental human necerokinin B precursor
04/30/2003CN1414858A Combinations of receptor tyrosine kinase inhibitor with a1-acidic glycoprotein binding organic compound
04/30/2003CN1414854A Phosphonate compounds
04/30/2003CN1414851A Method and formulation for treating resistance to antihypertensives and related conditions
04/30/2003CN1414848A Prevention of plaque rupure by ACAT inhibitors
04/30/2003CN1414834A Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein
04/30/2003CN1413728A Traditional Chinese medicine composition for treating coronary heart disease and its preparation method
04/30/2003CN1413726A Electuary for lowering blood pressure and health-care
04/30/2003CN1413724A Brain active effect matter for prevention and curing encephalopathy and developing intelligence and its preparation method
04/30/2003CN1413723A Method for extracting medicine from bluish dogbane
04/30/2003CN1413722A Chinese patent drug for treating thrombus obliterating angiitis
04/30/2003CN1413710A Capsule for treating piles with 9-medicinal herbs
04/30/2003CN1413707A Xinmai dripping pill
04/30/2003CN1413704A Huafeng pill
04/30/2003CN1413689A Medicine for treating cardiovascular and cerebrovascular system disease, apoplectic sequel
04/30/2003CN1413679A Medicine for removing obstruction in channels to thrombolytic
04/30/2003CN1413676A Large-capacity compound red sage root injection and its preparation method
04/30/2003CN1413672A Medicine for treating angiocardiopathy and cerebrovascular disease and preparation method
04/30/2003CN1413656A Weinakang for treating ischemic cerebrovascular disease and senile dementia and its preparation method
04/30/2003CN1413655A Medicine for treating ischemic angiocardiopathy and cerebrovascular disease and its preparation method
04/30/2003CN1413653A Chinese drugs for treating cardiovascular and cerebrovascular system disease and its preparation method
04/30/2003CN1413649A Pill for treating rheumatic carditis
04/30/2003CN1413642A Method for extracting chrysanthemum medicinal component and extract
04/30/2003CN1413617A Medicine of scabish oil for treating angiocardiopathy and cerebrovascular disease and tumor
04/30/2003CN1413615A Tongmailing pill and its preparation method
1 ... 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 ... 1595